Day One Biopharma Expands to ADCs with $55M Drug Acquisition
"Day One Biopharmaceuticals enhances pipeline, acquiring global rights to promising PTK7-targeting cancer drug DAY301, begins trial soon."
- Latest
- Trending
"Day One Biopharmaceuticals enhances pipeline, acquiring global rights to promising PTK7-targeting cancer drug DAY301, begins trial soon."
Qualcomm settles for $75M with shareholders over hidden sales practices; awaits judge's approval. Significant impact on investor trust and market ...
Exploring digital collectibles: Renowned artist pivots to NFTs, sparking intrigue and fraud concerns. Authenticity and vigilance in the spotlight.
"Longtime Monroe Finance Board Chair Michael Manjos resigns after 13 years, citing trust issues between finance and education boards."
Meta faces lawsuit by billionaire Andrew Forrest over fake crypto ads using his likeness, U.S. judge allows negligence and misappropriation ...
TA 35 index drops 0.09%. Energean, Camtek hit highs; Enlight, Shapir fall. Crude up 0.93%, gold up 0.42%, USD/ILS rises. ...
"Despite a market dip, Bitcoin futures funding rates suggest traders are still bullish, reflecting positive sentiment and potential support from ...
Catch up on biotech headlines: Zentalis faces FDA hold, Aerovate's major setback, Merck's new vaccine, and promising trials by Intra-Cellular ...
Dogecoin developer Mishaboar warns new crypto investors of overlooked risks, emphasizing education, protection from scams, and financial priority.
"House Bill allows crypto firms to dodge SEC rules, favoring weaker CFTC oversight. Critics warn it's a boon for wealthy ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.